Stocks · Health care · Pharmaceutical Preparations

Immunome Inc.

IMNM Clue Score30
United States Fiscal year ends December CIK 0001472012
19.55
+1.24%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
19.55 on 9 Oct 2026
30 22 14 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $14.25 14 Oct 2025 $14.10 15 Oct 2025 $16.35 16 Oct 2025 $16.49 17 Oct 2025 $15.67 20 Oct 2025 $16.25 21 Oct 2025 $16.74 22 Oct 2025 $15.90 23 Oct 2025 $16.06 24 Oct 2025 $15.69 27 Oct 2025 $16.60 28 Oct 2025 $16.39 29 Oct 2025 $15.76 30 Oct 2025 $15.98 31 Oct 2025 $16.07 3 Nov 2025 $17.00 4 Nov 2025 $15.41 5 Nov 2025 $15.35 6 Nov 2025 $15.50 7 Nov 2025 $15.24 10 Nov 2025 $16.44 11 Nov 2025 $17.52 12 Nov 2025 $17.43 13 Nov 2025 $16.51 14 Nov 2025 $17.14 17 Nov 2025 $18.13 18 Nov 2025 $17.86 19 Nov 2025 $17.69 20 Nov 2025 $17.51 21 Nov 2025 $18.53 24 Nov 2025 $18.65 25 Nov 2025 $18.30 26 Nov 2025 $18.63 28 Nov 2025 $18.42 1 Dec 2025 $18.32 2 Dec 2025 $17.09 3 Dec 2025 $19.37 4 Dec 2025 $20.09 5 Dec 2025 $19.76 8 Dec 2025 $19.64 9 Dec 2025 $19.06 10 Dec 2025 $20.30 11 Dec 2025 $19.49 12 Dec 2025 $19.57 15 Dec 2025 $22.64 16 Dec 2025 $23.48 17 Dec 2025 $19.78 18 Dec 2025 $19.95 19 Dec 2025 $21.44 22 Dec 2025 $22.03 23 Dec 2025 $21.73 24 Dec 2025 $22.33 26 Dec 2025 $21.71 29 Dec 2025 $21.60 30 Dec 2025 $21.18 31 Dec 2025 $21.48 2 Jan 2026 $20.82 5 Jan 2026 $19.71 6 Jan 2026 $19.75 7 Jan 2026 $19.98 8 Jan 2026 $20.45 9 Jan 2026 $21.07 12 Jan 2026 $20.57 13 Jan 2026 $20.14 14 Jan 2026 $20.76 15 Jan 2026 $22.85 16 Jan 2026 $22.41 20 Jan 2026 $23.88 21 Jan 2026 $24.87 22 Jan 2026 $25.82 23 Jan 2026 $25.87 26 Jan 2026 $25.43 27 Jan 2026 $25.70 28 Jan 2026 $24.75 29 Jan 2026 $25.07 30 Jan 2026 $24.62 2 Feb 2026 $26.14 3 Feb 2026 $26.97 4 Feb 2026 $26.41 5 Feb 2026 $24.00 6 Feb 2026 $24.88 9 Feb 2026 $24.50 10 Feb 2026 $24.93 11 Feb 2026 $23.41 12 Feb 2026 $22.44 13 Feb 2026 $22.16 17 Feb 2026 $22.69 18 Feb 2026 $21.99 19 Feb 2026 $22.14 20 Feb 2026 $21.50 23 Feb 2026 $21.80 24 Feb 2026 $22.12 25 Feb 2026 $22.14 26 Feb 2026 $21.89 27 Feb 2026 $21.86 2 Mar 2026 $22.21 3 Mar 2026 $21.54 4 Mar 2026 $22.52 5 Mar 2026 $20.95 6 Mar 2026 $21.04 9 Mar 2026 $21.33 10 Mar 2026 $21.86 11 Mar 2026 $21.40 12 Mar 2026 $20.99 13 Mar 2026 $20.36 16 Mar 2026 $20.36 17 Mar 2026 $20.71 18 Mar 2026 $20.62 19 Mar 2026 $20.83 20 Mar 2026 $20.01 23 Mar 2026 $20.75 24 Mar 2026 $20.21 25 Mar 2026 $20.30 26 Mar 2026 $20.41 27 Mar 2026 $19.61 30 Mar 2026 $19.30 31 Mar 2026 $21.87 1 Apr 2026 $22.45 2 Apr 2026 $21.84 6 Apr 2026 $21.48 7 Apr 2026 $21.58 8 Apr 2026 $21.70 9 Apr 2026 $22.46 10 Apr 2026 $21.67 13 Apr 2026 $22.62 14 Apr 2026 $22.90 15 Apr 2026 $23.39 16 Apr 2026 $23.26 17 Apr 2026 $24.63 20 Apr 2026 $24.25 21 Apr 2026 $23.85 22 Apr 2026 $23.78 23 Apr 2026 $22.99 24 Apr 2026 $23.56 27 Apr 2026 $23.49 28 Apr 2026 $23.71 29 Apr 2026 $22.95 30 Apr 2026 $22.94 1 May 2026 $22.73 4 May 2026 $23.33 5 May 2026 $23.11 6 May 2026 $23.27 7 May 2026 $22.19 8 May 2026 $22.44 11 May 2026 $23.00 12 May 2026 $22.69 13 May 2026 $22.20 14 May 2026 $22.02 15 May 2026 $20.88 18 May 2026 $19.90 19 May 2026 $19.66 20 May 2026 $21.53 21 May 2026 $22.96 22 May 2026 $21.66 26 May 2026 $21.91 27 May 2026 $22.11 28 May 2026 $22.54 29 May 2026 $21.83 1 Jun 2026 $20.78 2 Jun 2026 $19.34 3 Jun 2026 $19.81 4 Jun 2026 $19.68 5 Jun 2026 $18.58 8 Jun 2026 $18.61 9 Jun 2026 $18.39 10 Jun 2026 $18.16 11 Jun 2026 $18.36 12 Jun 2026 $18.38 15 Jun 2026 $18.07 16 Jun 2026 $17.91 17 Jun 2026 $18.53 18 Jun 2026 $18.74 22 Jun 2026 $19.18 23 Jun 2026 $19.33 24 Jun 2026 $19.75 25 Jun 2026 $19.40 26 Jun 2026 $19.96 29 Jun 2026 $21.04 30 Jun 2026 $21.19 1 Jul 2026 $21.49 2 Jul 2026 $23.61 6 Jul 2026 $23.90 7 Jul 2026 $24.39 8 Jul 2026 $24.01 9 Jul 2026 $24.17 10 Jul 2026 $23.35 13 Jul 2026 $22.80 14 Jul 2026 $22.59 15 Jul 2026 $22.92 16 Jul 2026 $22.20 17 Jul 2026 $22.32 20 Jul 2026 $22.16 21 Jul 2026 $22.78 22 Jul 2026 $22.88 23 Jul 2026 $22.01 24 Jul 2026 $22.21 27 Jul 2026 $22.58 28 Jul 2026 $23.22 29 Jul 2026 $23.11 30 Jul 2026 $23.08 31 Jul 2026 $22.76 3 Aug 2026 $23.01 4 Aug 2026 $25.06 5 Aug 2026 $25.52 6 Aug 2026 $25.82 7 Aug 2026 $25.03 10 Aug 2026 $25.69 11 Aug 2026 $26.25 12 Aug 2026 $27.99 13 Aug 2026 $26.42 14 Aug 2026 $27.20 17 Aug 2026 $27.40 18 Aug 2026 $27.56 19 Aug 2026 $29.83 20 Aug 2026 $28.08 21 Aug 2026 $28.52 24 Aug 2026 $28.01 25 Aug 2026 $29.39 26 Aug 2026 $28.75 27 Aug 2026 $28.87 28 Aug 2026 $27.57 31 Aug 2026 $27.41 1 Sep 2026 $27.07 2 Sep 2026 $27.33 3 Sep 2026 $27.16 4 Sep 2026 $26.76 8 Sep 2026 $26.81 9 Sep 2026 $26.12 10 Sep 2026 $24.97 11 Sep 2026 $24.67 14 Sep 2026 $24.55 15 Sep 2026 $23.95 16 Sep 2026 $23.46 17 Sep 2026 $23.93 18 Sep 2026 $23.97 21 Sep 2026 $25.07 22 Sep 2026 $25.75 23 Sep 2026 $24.24 24 Sep 2026 $22.34 25 Sep 2026 $21.41 28 Sep 2026 $21.68 29 Sep 2026 $21.89 30 Sep 2026 $21.51 1 Oct 2026 $20.89 2 Oct 2026 $20.90 5 Oct 2026 $21.17 6 Oct 2026 $19.31 7 Oct 2026 $19.10 8 Oct 2026 $19.31 9 Oct 2026 $19.55 SIEGALL CLAY B President and CEO Bought $999.99K 18 Dec 2025 · at $21.50 · 5.8% of stake SIEGALL CLAY B President and CEO Bought $149.05K 19 Dec 2025 · at $20.48 · 0.9% of stake Tsai Philip Chief Technical Officer Bought $204.90K 19 Dec 2025 · at $20.49 · 30.0% of stake Barchas Isaac Director Sold on a plan $8.33M 22 Dec 2025 · at $21.74 · 15.9% of stake SIEGALL CLAY B President and CEO Bought $100.02K 30 Dec 2025 · at $21.15 · 0.7% of stake BIENAIME JEAN JACQUES Director Bought $22.12K 10 Mar 2026 · at $22.12 · 2.7% of stake BIENAIME JEAN JACQUES Director Bought $21.55K 11 Mar 2026 · at $21.55 · 2.7% of stake WAGENHEIM PHILIP Director Sold at will $753.30K 20 Mar 2026 · at $20.47 · 9.1% of stake WAGENHEIM PHILIP Director Sold at will $582.33K 23 Mar 2026 · at $20.65 · 7.6% of stake SIEGALL CLAY B President and CEO Bought $500.60K 27 Mar 2026 · at $19.67 · 3.8% of stake Higgins Jack Chief Scientific Officer Sold on a plan $204.24K 2 Apr 2026 · at $21.64 · 30.0% of stake Rosett Max Chief Financial Officer Sold on a plan $1.42M 2 Apr 2026 · at $21.92 · 54.6% of stake BIENAIME JEAN JACQUES Director Bought $103.50K 15 May 2026 · at $20.70 · 13.0% of stake BIENAIME JEAN JACQUES Director Sold at will $203.82K 5 Jun 2026 · at $19.41 · 24.2% of stake BIENAIME JEAN JACQUES Director Bought $204.26K 5 Jun 2026 · at $19.45 · 31.9% of stake Rosett Max Chief Financial Officer Sold on a plan $1.09M 15 Jun 2026 · at $18.23 · 52.6% of stake Lechleider Robert Chief Medical Officer Sold on a plan $1.09M 25 Jun 2026 · at $19.85 · 77.7% of stake Barchas Isaac Director Sold on a plan $2.13M 30 Jun 2026 · at $21.12 · 24.7% of stake Lechleider Robert Chief Medical Officer Sold on a plan $1.24M 2 Jul 2026 · at $22.62 · 77.7% of stake Barchas Isaac Director Sold on a plan $2.26M 2 Jul 2026 · at $22.59 · 32.4% of stake Barchas Isaac Director Sold on a plan $2.00M 6 Jul 2026 · at $24.11 · 39.9% of stake Horn Kinney CHIEF BUSINESS OFFICER Sold on a plan $27.30K 7 Jul 2026 · at $25.00 · 100% of stake Barchas Isaac Director Sold on a plan $409.13K 7 Jul 2026 · at $24.20 · 13.5% of stake Horn Kinney CHIEF BUSINESS OFFICER Sold on a plan $2.27M 4 Aug 2026 · at $25.09 · 100% of stake Barchas Isaac Director Sold on a plan $543.09K 6 Aug 2026 · at $26.06 · 19.2% of stake Barchas Isaac Director Sold on a plan $397.36K 7 Aug 2026 · at $26.06 · 17.4% of stake Barchas Isaac Director Sold on a plan $263.96K 10 Aug 2026 · at $26.07 · 14.0% of stake Barchas Isaac Director Sold on a plan $1.63M 11 Aug 2026 · at $26.23 · 100% of stake Barchas Isaac Director Sold on a plan $301.06K 12 Aug 2026 · at $27.25 · 10.7% of stake Higgins Jack Chief Scientific Officer Sold on a plan $334.22K 11 Sep 2026 · at $25.32 · 16.9% of stake
9 buys3 sales at will18 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$6.94M
Net income
$212.39M
Free cash flow
$200.60M
Operating margin
-3,228.8%
Net margin
-3,060.0%
Return on equity
-33.5%
Return on capital
-27.9%
Debt to equity
0.00
Revenue growth, 1 yr
-23.2%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -18M FY20 Fiscal year 2020 Revenue $0.00 Net income $17.84M Margin n/a 0K -25M FY21 Fiscal year 2021 Revenue $0.00 Net income $24.71M Margin n/a 0K -37M FY22 Fiscal year 2022 Revenue $0.00 Net income $36.90M Margin n/a 14M -107M FY23 Fiscal year 2023 Revenue $14.02M Net income $106.81M Margin -761.9% 9M -293M FY24 Fiscal year 2024 Revenue $9.04M Net income $292.96M Margin -3,240.4% · growth -35.5% 7M -212M FY25 Fiscal year 2025 Revenue $6.94M Net income $212.39M Margin -3,060.0% · growth -23.2%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
11 Sep 2026 Higgins Jack
Chief Scientific Officer
Sold on a plan $334.22K 16.9%
12 Aug 2026 Barchas Isaac
Director
Sold on a plan $301.06K 10.7%
11 Aug 2026 Barchas Isaac
Director
Sold on a plan $1.63M 100%
10 Aug 2026 Barchas Isaac
Director
Sold on a plan $263.96K 14.0%
7 Aug 2026 Barchas Isaac
Director
Sold on a plan $397.36K 17.4%
6 Aug 2026 Barchas Isaac
Director
Sold on a plan $543.09K 19.2%